Focus on quetiapine: The fourth atypical antipsychotic

Formulary

Volumn 33, Issue 2, 1998, Pages 105-119

  Caley, Charles F ^a   Rosenbaum, Susan ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002070018     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cardoni AA, Myer S. Sertindole: An atypical antipsychotic for the treatment of schizophrenia. Formulary 1997;32:907-25.
2. Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994;55(Suppl B):47-52.
3. Lahti AC, Tamminga CA. Recent developments in the neuropharmacology of schizophrenia. Am J Health-Syst Pharm 1995;52(Suppl 1):S5-S8.
4. Meltzer HY. Pre-clinical pharmacology of atypical antipsychotic drugs: A selective review. Br J Psychiatry 1996;168 (Suppl 29):23-31.
5. Richelson E. Preclinical pharmacology of neuroleptics: Focus on new generation compounds. J Clin Psychiatry 1996;57 (Suppl 11):4-11.
6. Saller CF, Salama AI. Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology 1993;112:285-92.
7. Seroquel (quetiapine fumarate) package insert. Zeneca Pharmaceuticals, Wilmington, DE, October 1997.
8. Bymaster FP, Calligaro DO, Falcone JF, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996;14:87-96.
9. 4 receptors. Neuropsychopharmacology 1997;16:93-110.
10. Ereshefsky L. Pharmacokinetics and drug interactions: Update for new antipsychotics. J Clin Psychiatry 1996;57(Suppl 11):12-25.
11. Thyrum PT, Fabre LF, Wong YJ, et al. Multiple-dose pharmacokinetics of ICI 204,636 in schizophrenic men and women [abstract]. Psychopharmacol Bull 1996;32:525.
12. Thyrum PT, Jaskiw G, Fuller M, et al. Multiple-dose pharmacokinetics of ICI 204,636 in elderly patients with selected psychotic disorders [abstract]. Psychopharmacol Bull 1996;32:524.
13. Wong YWJ, Ewing BJ, Thyrum PT, Yeh C. Pharmacokinetics of 'Seroquel' (quetiapine) in hepatic and renal insufficiency [abstract]. Schizophr Res 1997;24:200.
14. Grimm SW, Stams KR, Bui K. In vitro prediction of potential metabolic drug interactions for Seroquel [abstract]. Schizophr Res 1997;24:198.
15. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995;15:387-98.
16. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-20.
17. Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-46.
18. Wetzel H, Szegedi A, Hain C, et al. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: Results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Psychopharmacology 1995;119:231-8.
19. Borison RL, Arvanitis LA, Miller BG, and the U.S. Seroquel Study Group. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 1996;16:158-69.
20. Peuskens J, Link CGG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997;96:265-73.
21. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997;54:549-57.
22. Arvanitis LA, Rak IW. The long-term efficacy and safety of 'Seroquel' (quetiapine) [abstract]. Schizophr Res 1997;24:196-7.
23. Risperdal (risperidone) package insert. Janssen Pharmaceutica, Titusville, NJ, December 1994.
24. Zyprexa (olanzapine) package insert. Eli Lilly, Indianapolis, IN, September 1996.
25. Ghaeli P, Dufresne RL. Serum triglyceride levels in patients treated with clozapine. Am J Health-Syst Pharm 1996;53:2079-81.
26. Wong YWJ, Ewing BJ, Thyrum PT, Yeh C. The effect of phenytoin and cimetidine on the pharmacokinetics of Seroquel [abstract]. Schizophr Res 1997;24:200.
27. Wong YWJ, Ewing BJ, Thyrum PT, et al. Effects of haloperidol, risperidone, and thioridazine on the pharmacokinetics of quetiapine [abstract]. Presented at the New Clinical Drug Evaluation Unit (NCDEU); May 1997; Boca Raton, FL.
28. Potkin SG, Thyrum PT, Bera R, et al. Pharmacokinetics and safety of lithium co-administered with 'Seroquel' (quetiapine) [abstract]. Schizophr Res 1997;24:199.
29. Zeneca Seroquel shows no evidence of dose-related extrapyramidal symptoms in schizophrenia trials. The Pink Sheet 1997(Oct 6):4.
30. Tamminga CA. Brain mechanisms of antipsychotic drug actions. Presented at the annual meeting of the American Psychiatric Association; May 7, 1996; New York, NY.